Bayern Kapital invests in Vantis with Growth Fund 2

Landshut/Munich — Bayern Kapi­tal, the venture and growth capi­tal company of the Free State of Bava­ria, is inves­t­ing in Vantis, an inno­va­tive provi­der of hybrid care for chro­ni­cally ill pati­ents using digi­tal solu­ti­ons in combi­na­tion with regu­lar visits to the doctor, through its Bayern 2 growth fund. — Twip Impact Ventures and the exis­ting inves­tors first­mi­nute capi­tal and b2venture are also parti­ci­pa­ting in the Series A finan­cing round led by Ange­lini Ventures in the double-digit million range. 

The funds from the finan­cing round will prima­rily be used to further expand the team and the data-driven, proac­tive manage­ment of chro­ni­cally ill pati­ents, as well as to expand the network of GP prac­ti­ces opera­ted by Vantis.

When caring for pati­ents with chro­nic illnesses, such as cardio­vas­cu­lar dise­a­ses, it is important to provide regu­lar outpa­ti­ent care and acute emer­gency care as well as conti­nuous long-term care and support for pati­ents in their ever­y­day lives, ideally tail­o­red to their indi­vi­dual needs. The latter in parti­cu­lar are often complex and require conti­nuous moni­to­ring of the patient’s state of health and vital signs. At the same time, the demand for appro­priate care is conti­nuously incre­asing as demo­gra­phic change progres­ses, while a shortage of doctors is threa­tening to lead to a lack of care, parti­cu­larly in rural regi­ons. Hubert Aiwan­ger (Bava­rian Minis­ter of Econo­mic Affairs) explains: “Demo­gra­phic change and the resul­ting increase in the number of chro­nic illnesses in the popu­la­tion means that inno­va­tive approa­ches are needed for the health­care system. With its combi­na­tion of digi­tal and perso­nal care, Vantis shows what such inno­va­tions can look like. The company is a good exam­ple of a Bava­rian company that is successful on the market as a ‘first mover’ with a future-proof busi­ness model. It demons­tra­tes the inno­va­tive strength and future viabi­lity of the Bava­rian tech­no­logy sector.” 

Vantis addres­ses the chall­enge of under­sup­ply in particular.

The company has set itself the goal of ensu­ring opti­mal care and making it simp­ler and more effi­ci­ent for pati­ents and doctors. Foun­ded in 2019, the company combi­nes inno­va­tive digi­tal treat­ment methods such as tele­me­di­cine, data-driven remote moni­to­ring and support from arti­fi­cial intel­li­gence (AI) with tail­o­red, pati­ent-cente­­red care from GPs to create digi­tal long-term therapy for chro­ni­cally ill patients. 

“The digi­tal trans­for­ma­tion of the health­care system requi­res considera­ble invest­ment to ensure that ever­yone bene­fits in the end — doctors, pati­ents and payers. As a digi­tal health­care company with our own prac­ti­ces, we have the unique oppor­tu­nity to tailor our tech­no­logy to the current and future chal­lenges in GP care and to conti­nuously opti­mize it. Our goal is to achieve better treat­ment outco­mes for pati­ents and to make doctors’ ever­y­day work easier so that they can focus more on medi­cal care,” says Till Jansen, CEO of Vantis.

“We invest in young compa­nies that are prepared to chall­enge the status quo and bring inno­va­tions to the market. With the combi­na­tion of its own GP prac­ti­ces and comple­men­tary digi­tal health appli­ca­ti­ons, Vantis is pursuing the goal of sustain­ably impro­ving GP care for doctors and pati­ents. This forward-looking stra­tegy makes Vantis a promi­sing invest­ment for us. The company offers a solu­tion that is in tune with the times and addres­ses the growing requi­re­ments in the health­care market. In addi­tion, Vantis has a diver­si­fied, solid busi­ness model and attrac­tive growth pros­pects,” says Monika Steger (photo), Co-Mana­­ging Direc­tor of Bayern Kapi­tal.

About Vantis

Vantis is a Munich-based company and a pioneer in digi­tal health­care. The company addres­ses one of the biggest chal­lenges in the German health­care system: more pati­ents, fewer doctors. Through the targe­ted use of digi­tal tech­no­lo­gies and inno­va­tive treat­ment methods, Vantis combi­nes the best of medi­cine, tech­no­logy and effi­ci­ent prac­tice orga­niza­tion. To this end, Vantis is inves­t­ing in its own network of gene­ral medi­cal prac­ti­ces to ensure compre­hen­sive, future-proof medi­cal care. www.vantis-health.com/de/

About Bayern Kapital

Bayern Kapi­tal GmbH, based in Lands­hut, is the venture/growth capi­tal company of the Free State of Bava­ria. It supports inno­va­tive high-tech and deep-tech compa­nies in Bava­ria through various growth phases, from seed to later stage, with equity capi­tal of EUR 0.25 to 25 million. Bayern Kapi­tal often closes gaps in the VC sector in proven consor­tium constel­la­ti­ons with private investors. 

Bayern Kapi­tal mana­ges specia­li­zed invest­ment funds with a volume of around 700 million euros. Since its foun­da­tion in 1995, the wholly-owned subsi­diary of LfA Förder­bank Bayern has inves­ted over 500 million euros of its own equity capi­tal in more than 320 start-ups and scale-ups from sectors such as life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. This has crea­ted over 10,000 perma­nent jobs in sustainable compa­nies in Bava­ria. The active port­fo­lio curr­ently compri­ses almost 100 companies.

Examp­les of nume­rous ground­brea­king success stories that Bayern Kapi­tal has been invol­ved in at an early stage include EOS (today the world’s leading tech­no­logy provi­der in indus­trial 3D prin­ting of metals and plas­tics), Proglove, Fazua, SimS­cale, Scom­pler, egym, Parcel­lab, Cobrai­ner, Quan­tum Systems, Casavi, Riskme­thods, Tubu­lis, Cata­lym, Immu­nic, Sirion, tado and many more. www.bayernkapital.de